MSLP News Alert Muscle Pharm Corp (MSLP) 8.2500 02/15/2015 0

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Muscle Pharm Corp (MSLP) 8.2500 $MSLP

I Made An Error In Switching To FitLife
Paulo Santos - at Seeking Alpha - Wed Feb 11, 8:45AM CST


MusclePharm: All Show, No Strength
Value Vista UK - at Seeking Alpha - Tue Feb 10, 1:32PM CST


FitLife Brands Has Lower Risk With Possibly Similar Upside To MusclePharm
Paulo Santos - at Seeking Alpha - Sat Feb 07, 10:17AM CST

GNC: 48.11 (-0.55)

MusclePharm Expands Partnership With Brand Ambassador Tiger Woods
Marketwired - Thu Jan 29, 9:00AM CST
MusclePharm Corporation (OTCQB: MSLP), a scientifically driven, performance-lifestyle sports nutrition company, today announced that brand ambassador Tiger Woods will debut a new MusclePharm-branded water bottle in his first PGA Tour start of the year at this week's Waste Management Phoenix Open. Woods already carries a MusclePharm-branded golf bag as part of a multi-year endorsement deal signed last year.

Why Is MusclePharm Doing So Badly? Here's My Best Guess
Paulo Santos - at Seeking Alpha - Thu Jan 29, 8:12AM CST


Could MusclePharm Be Ready To Bulk Up Your Portfolio?
Andrew Labutka - at Seeking Alpha - Tue Jan 06, 8:17AM CST


These Supplement Companies Are Doing Some Heavy Lifting in the Market
ACCESSWIRE - Thu Dec 18, 10:39AM CST
CORAL GABLES, FL / ACCESSWIRE / December 18, 2014 / What started in the "grass roots" is now a multi-billion dollar a year industry. According to IBISWorld, the global market for vitamin and supplement products is expected to have a compound annual growth rate of 7.4%, and is currently valued at $18 billion in revenue. The data cites that these "impressive growth figures in the past five years" are a result of Americans becoming more health conscious and disposable income levels recovering from the recession.

Market Overreaction An Early Holiday Gift, MusclePharm Trading At Less Than Half Of Intrinsic Value
Mark T. Phillips - at Seeking Alpha - Wed Dec 17, 12:38PM CST

GNC: 48.11 (-0.55)

Combing Fund Holdings (Frost Gamma Investment Trust ) For Ideas
Devon Shire - at Seeking Alpha - Wed Dec 10, 9:04AM CST

ROX: 1.50 (unch), TEVA: 56.77 (-0.58), LTS: 3.92 (-0.02)

InsiderInsights.com Daily Round Up 11/25/14: AAPL, FCF, AVID, SC
InsiderInsights - at Seeking Alpha - Wed Nov 26, 12:20AM CST

SC: 22.11 (+0.38), ACMP: 48.15 (-3.60), NEOT: 6.69 (-0.04), BBY: 39.11 (-0.08), SGM: 10.68 (+0.08), FIVE: 33.01 (+0.11), AVID: 14.12 (+0.34), FCF: 8.62 (-0.10), SPW: 87.37 (-2.81), NLNK: 38.84 (+1.51), AINC: 140.00 (-3.25), PF: 36.18 (-0.21), AAPL: 127.08 (+0.62), SFXE: 3.49 (+0.01), INTU: 90.25 (+0.86), CSCO: 29.43 (-0.03), FOLD: 8.36 (-0.11), KPTI: 27.12 (-0.13)

Investment Banker Dick Huebner On How To Uncover Micro-Cap Biotechs That Deliver On Promises
Life Sciences Report - Seeking Alpha - Fri Nov 21, 9:37AM CST
Micro-cap stocks suffer from all sorts of ills. They are often illiquid, and companies can be unable to raise new funds under reasonable terms, if at all. Investing in these equities requires extraordinary expertise and experience, and that is where...
VNRX: 4.15 (+0.15), EXAS: 25.56 (-0.54)

Market Maker Surveillance Report. ATEA, NVGN, PANL, AMCF, VPCO, MSLP, Losing Stocks With Lowest Price Friction For Monday, November 17th 2014
M2 - Tue Nov 18, 3:11AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 4654 companies with "abnormal" market making, 2049 companies with positive Friction Factors and 3121 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Monday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Astea International Inc (NASDAQ:ATEA), Novogen Ltd (NASDAQ:NVGN), Universal Display Corp (NASDAQ ANL), Andatee China Marine Fuel Services Corp (NASDAQ:AMCF), Vapor Corp (OTC:VPCO), MusclePharm Corp (OTC:MSLP). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
OLED: 35.57 (+0.32), PANL: 2.63 (-0.41), NVGN: 2.79 (+0.17), AMCF: 1.44 (+0.01), VPCO: 1.02 (+0.01), ATEA: 1.76 (+0.01)

MusclePharm's (MSLP) CEO Brad Pyatt on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 17, 1:53PM CST


MusclePharm off after earnings miss
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 9:52AM CST


MusclePharm Reports 2014 Third-Quarter Financial Results
Marketwired - Fri Nov 14, 4:00PM CST
MusclePharm Corporation (OTCQB: MSLP), a scientifically driven, performance-lifestyle sports nutrition company today announced financial results for the third quarter ended September 30, 2014.

UPDATE: MusclePharm to Report 2014 Third Quarter Financial Results on Friday, November 14, 2014
Marketwired - Wed Nov 12, 11:04AM CST
MusclePharm Corporation (OTCQB: MSLP), a scientifically-driven, performance-lifestyle sports nutrition company, will report its financial results for the third quarter ended September 30, 2014 on Friday, November 14, 2014, after market close.

MusclePharm to Report 2014 Third Quarter Financial Results on Friday, November 14, 2014
Marketwired - Wed Nov 12, 7:05AM CST
MusclePharm Corporation (OTCQB: MSLP), a scientifically-driven, performance-lifestyle sports nutrition company, will report its financial results for the third quarter ended September 30, 2014 on Friday, November 14, 2014, after market close.

MusclePharm Corp.: An Undiscovered Growth Story With Over 80% Upside
Mark T. Phillips - at Seeking Alpha - Thu Oct 23, 10:41AM CDT

KO: 41.99 (-0.18), PEP: 99.13 (-1.14)

MusclePharm CMO quits
Seeking Alpha - at Seeking Alpha - Tue Oct 21, 6:54AM CDT


El Tigre Silver Corp. Appoints Three New Directors
PR Newswire - Fri Oct 17, 5:06PM CDT
El Tigre Silver Corp. ("El Tigre" or the"Company" (TSXV: ELS) (Frankfurt: 5RT) (OTCQX: EGRTF) is pleased to announce the appointments of John H. Bluher, Patrick L. Avery and Ron Hodgson to the Company's Board of Directors ("Board" effective immediately.
ELS.VN: 0.170 (-0.010)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 34

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 44

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 41

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 39

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 31

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Knee Treatment with Overture's Latest System

Updated Category News Views 312

Full Commercial Launch of the OvertureTi Knee Resurfacing System Overture Orthopaedics is making headlines as it proudly announces the full commercial launch of its advanced OvertureTi Knee Resurfacing System. This medical device targets early osteoarthritis and cartilage defects effectively, presenting a breakthrough for patients seeking alternatives to traditional joint...

Continue Reading
Elis SA: Key Insights on Recent Share Buyback Activities

Updated Category News Views 130

Elis SA's Recent Share Buyback Activities Elis SA has made a mark with its recent trading activities associated with its own shares, particularly highlighting a series of transactions carried out during a specified period. Overview of the Buyback Program As part of its strategic financial planning, Elis has engaged in a buyback program that has garnered attention. The...

Continue Reading
Kevin O'Leary's Essential Advice for Startups on Content Investment

Updated Category News Views 262

O'Leary: Tools Are Cheap, But Talent Isn't Entrepreneur and "Shark Tank" star Kevin O'Leary emphasizes a critical insight for startups: while the cost of creating digital content has drastically reduced, the true value comes from the talent that produces it. O'Leary shared his thoughts in a recent video, indicating that although the cost of technology has significantly...

Continue Reading
The St. James Reinvents Lacrosse with Spencer Ford at the Helm

Updated Category News Views 237

The St. James Strengthens Lacrosse Initiatives In an exciting development, The St. James has appointed Spencer Ford as the new Director of Lacrosse, ushering in a transformative approach to lacrosse for both boys and girls. With a vast wealth of experience spanning nearly twenty years, Ford is not only a seasoned professional player but also an accomplished coach and...

Continue Reading
Hudbay Minerals Celebrates Permit Approval for Copper World

Updated Category News Views 119

Hudbay Minerals Receives Final Permit for Copper World Project Hudbay Minerals Inc. (TSX, NYSE: HBM), a prominent player in the mining industry, has taken a significant step forward by securing the final major permit necessary for its Copper World project in Arizona. This milestone not only enhances the company’s operational capacity but also solidifies its commitment...

Continue Reading